• --Backbone NMR resonance assignments for the VP1u N-terminal receptor-binding domain of the human parvovirus pathogen B19
• A Multiplex Fluorescence of Loop Primer Upon Self-Dequenching Loop-Mediated Isothermal Amplification Assay for the Detection of Epstein-Barr Virus and Human Parvovirus B19 in Clinical Transplant Samples
• ABO-incompatible living donor kidney transplantation failure due to acute blood group antibody-dependent rejection triggered by human parvovirus B19 infection: a case report and literature review
• Adult-Onset Still's Disease: An Atypical Presentation Refractory to Standard Treatment
• An Outbreak of Parvovirus B19 in Israel
• An unusual outbreak of parvovirus B19 infections, France, 2023 to 2024
• An Update on Viral Infection-Associated Collapsing Glomerulopathy
• Antiviral alternatives against important members of the subfamily Parvovirinae: a review
• Association between Parvovirus B19 and thyroid/celiac autoantibodies among T1DM pediatric patients
• Association between serological indicators of past contacts with Herpesviridae and a slower resolution of chronic spontaneous urticaria in children
• Backbone NMR resonance assignments for the VP1u N-terminal receptor-binding domain of the human parvovirus pathogen B19
• Backbone NMR resonance assignments for the VP1u N-terminal receptor-binding domain of the human parvovirus pathogen B19
• Celastrol attenuates human parvovirus B19 NS1‑induced NLRP3 inflammasome activation in macrophages
• Changing epidemiology of parvovirus B19 in the Netherlands since 1990, including its re-emergence after the COVID-19 pandemic
• Clinical and immune features of human parvovirus B19 infection in allogeneic stem cell transplantation recipients: A retrospective monocentric study
• Clinical characteristics of human parvovirus B19 infection after allogeneic stem cell transplantation
• Clinical Presentation of Parvovirus B19 Infection in Adults Living with HIV/AIDS: A Case Series
• Coinfections and comorbidities observed in COVID-19 during the influenza season in the pediatric patient
• Decreasing parvovirus B19 and hepatitis A nucleic acid test positivity rates in Canadian plasma donors following the initiation of COVID-19 restriction in March 2020
• Dengue virus serotype 2 genotype III evolution during the 2019 outbreak in Mato Grosso, Midwestern Brazil
• Detection of Parvovirus B19 genome in human heart tissue samples
• Differential diagnosis of fever and rash cases negative for measles and rubella to complement surveillance activities
• Distinct clinical features of transplanted children with Parvovirus B19 infection
• Effect of the Functional VP1 Unique Region of Human Parvovirus B19 in Causing Skin Fibrosis of Systemic Sclerosis
• Embryology, Teratology TORCH
• Encephalopathy Caused by Human Parvovirus B19 Genotype 1 Associated with <em>Haemophilus influenzae</em> Meningitis in a Newborn
• Encephalopathy Caused by Human Parvovirus B19 Genotype 1 Associated with Haemophilus influenzae Meningitis in a Newborn
• Epidemic of parvovirus B19 and disease severity in pregnant people, Denmark, January to March 2024
• Epidemiological characterization of viral etiological agents of the central nervous system infections among hospitalized patients in Egypt between 2016 and 2019
• Erythema Infectiosum
• Evaluation of viral infection as an etiology of ME/CFS: a systematic review and meta-analysis
• Extreme upsurge of parvovirus B19 resulting in severe fetal morbidity and mortality
• First report on severe septic shock associated with human Parvovirus B19 infection after cardiac surgery
• For better or worse: crosstalk of parvovirus and host DNA damage response
• Globoside and the mucosal pH mediate parvovirus B19 entry through the epithelial barrier
• Globoside Is an Essential Intracellular Factor Required for Parvovirus B19 Endosomal Escape
• Hematologic Manifestations of Parvovirus B19 Infection
• Hemophagocytic Syndrome Secondary to Human Parvovirus B19 Infection in an Acquired Immunodeficiency Syndrome Patient:Report of One Case
• HERV-K np9 and HERV-R env: Two endogenous retrovirus products with potential Pathogenic roles in pediatric acute lymphoblastic leukemia
• High Epstein-Barr virus capsid antigen IgG level associates with the carriership of CD8+ T cell somatic mutations in the STAT3 SH2 domain
• Human herpesvirus-6, HHV-8 and parvovirus B19 after allogeneic hematopoietic cell transplant: the lesser-known viral complications
• Human parvovirus B19 infection in malignant and benign tissue specimens of different head and neck anatomical subsites
• Immune checkpoint inhibitor-induced neurotoxicity is not associated with seroprevalence of neurotropic infections
• Importin α/β-dependent nuclear transport of human parvovirus B19 nonstructural protein 1 is essential for viral replication
• Intrauterine Blood Transfusion for Parvo B19-Induced Fetal Anemia: Neuroimaging Findings and Long-Term Neurological Outcomes
• Investigation of Parvovirus B19, Cytomegalovirus, Herpes Simplex Virus Types 1 and 2, Human Papillomavirus Types 16 and 18 in Papillary Thyroid Carcinoma
• Lamivudine induced pure red cell aplasia and HIV-1 drug resistance-associated mutations: a case report
• Letter to the editor: Severe parvovirus B19 infections in the immunocompetent population
• New atypical epidemiological profile of parvovirus B19 revealed by molecular screening of blood donations, France, winter 2023/24
• Non-Permissive Parvovirus B19 Infection: A Reservoir and Questionable Safety Concern in Mesenchymal Stem Cells
• Novel Nucleic Acid Detection for Human Parvovirus B19 Based on <em>Pyrococcus furiosus</em> Argonaute Protein
• On-column refolding and off-column assembly of parvovirus B19 virus-like particles from bacteria-expressed protein
• Papular purpuric gloves and socks syndrome bei Parvovirus-B19-Primärinfektion
• Papular-Purpuric "Gloves and Socks" Syndrome in Parvovirus B19 Infection
• Parvovirus B19 in Pregnancy
• Parvovirus B19 in stem cell transplantation
• Parvovirus B19 Infection and Pregnancy: Review of the Current Knowledge
• Parvovirus B19 Infection in Adults: A Case Series
• Parvovirus B19 Outbreak in Israel: Retrospective Molecular Analysis from 2010 to 2023
• Parvovirus in Kidney Transplant Recipients: A Single-Center Experience
• Plasma metagenomics reveals regional variations of emerging and re-emerging pathogens in Chinese blood donors with an emphasis on human parvovirus B19
• Post-COVID-19 pandemic outbreak of severe Parvovirus B19 primary infections in Paris, France: 10-year interrupted time-series analysis (2012-2023)
• Pre-Existing Intrarenal Parvovirus B19 Infection May Relate to Antibody-Mediated Rejection in Pediatric Kidney Transplant Patients
• Reconstruction of the historic time course of blood-borne virus contamination of clotting factor concentrates, 1974-1992
• RELATIONSHIP BETWEEN PARVOVIRUS B19 AND OSTEOARTHRITIS: LITERATURE REVIEW
• Role of clinical, molecular, and serological features in the diagnosis of parvovirus B19 infection in children
• Role of Coxsackievirus B3-Induced Immune Responses in the Transition from Myocarditis to Dilated Cardiomyopathy and Heart Failure
• Seroepidemiology of Human Parvovirus B19 Infection among the Population of Vojvodina, Serbia, over a 16-Year Period (2008-2023)
• Seroinfection of Antibodies to Toxoplasma gondii, Parvovirus B19, Treponema pallidum, and HIV in a Pregnant Attending a Medical Center in Northern Peru
• Severe myelosuppression involving HPV-B19 infection and NUDT15 polymorphisms during therapy for LCH
• Sickle Cell Nephropathy
• Sickle Cell Nephropathy
• Solid-Phase Extraction and Enhanced Amplification-Free Detection of Pathogens Integrated by Dual-Functional CRISPR-Cas12a
• Solid-Phase Extraction and Enhanced Amplification-Free Detection of Pathogens Integrated by Multifunctional CRISPR-Cas12a
• Surveillance of Erythrovirus B19 (B19V) in patients with acute febrile illness suspected of arboviruses in Mato Grosso do Sul state, Brazil
• TCRalphabeta-depleted hematopoietic stem cell transplant and third-party CD45RA(+) depleted adoptive cell therapy for treatment of post-transplant parvovirus B19 aplastic crisis
• The 507th case: hemolytic anemia, parvovirus B19, and multiple organ dysfunction
• The epidemiological and genetic characteristics of human parvovirus B19 in patients with febrile rash illnesses in China
• The plasma viral communities associate with clinical profiles in a large-scale haematological patients cohort
• The relationship between infectious agents and juvenile dermatomyositis: a narrative update from the pediatric perspective
• Transfusion Transmitted Disease
• Treating Parvovirus Triggered Refractory Hemolytic Anemia with Rituximab in Renal Transplant Recipients - A Report of Two Cases
• Vertical Transplacental Infections
• Viral DNAemia and DNA Virus Seropositivity and Mortality in Pediatric Sepsis
• Viral etiology of measles-like rash in Guinean children during the COVID epidemic in 2022
• Viral Myocarditis as a Factor Leading to the Development of Heart Failure Symptoms, Including the Role of Parvovirus B19 Infection-Systematic Review
• Viral myocarditis in combination with genetic cardiomyopathy as a cause of sudden death. An autopsy series
• Viral-induced inflammation can lead to adverse pregnancy outcomes
• Viruses associated with measles-like illnesses in Uganda